Global Drug Delivery Partnering 2010-2015 - Deal Trends, Players and Financials Analysis

News provided by

Nov 16, 2015, 02:10 ET

Logo

DUBLIN, Nov. 16, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/2jdl37/global_drug) has announced the addition of the "Global Drug Delivery Partnering 2010-2015: Deal trends, players and financials" report to their offering.

The Global Drug Delivery Partnering 2010-2015 report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides a detailed understanding and analysis of how and why companies enter drug delivery partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors drug delivery technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.

Drug Delivery

Bioavailability
Implanatable
Oral delivery
Rapid release
Delayed release
Parenteral
Infusion
Injectable
Pro-drug
Targeted
Topical
Transdermal
Buccal
Inhaled
Nasal
Ocular
Rectal
Sublingual
Urogenital

Global Drug Delivery Partnering 2010-2015 includes:

Trends in drug delivery dealmaking in the biopharma industry since 2010
Analysis of drug delivery deal structure and contract documents
Access to headline, upfront, milestone and royalty data
Case studies of real-life drug delivery deals
Access to over 2,000 drug delivery deals announced
The leading drug delivery deals by value since 2010
Most active drug delivery dealmakers since 2010
The leading drug delivery partnering resources

In Global Drug Delivery Partnering 2010-2015, the available contracts are listed by:

Company A-Z
Headline value
Stage of development at signing
Deal component type
Specific therapy target

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in drug delivery dealmaking

Chapter 3 - Leading drug delivery deals

Chapter 4 - Big pharma drug delivery deals

Chapter 5 - Big biotech drug delivery deals

Chapter 6 - Drug delivery partnering contracts directory

Chapter 7 - Drug delivery dealmaking by technology type

Companies Mentioned

3M
3M Drug Delivery Systems
AAIPharma Services
Abbott
Accredo Health Group
Acelrx Pharmaceuticals
Acorda Therapeutics
Actavis
Actelion
Actient Pharmaceuticals
Adeona Pharmaceuticals
Adolor
Alchemia
Aldexa Therapeutics
Alexza Pharmaceuticals
Alfacell
Alimera Sciences
Alkermes
Allergan
Allos Therapeutics
Amag Pharmaceuticals
AMAG Pharmaceuticals
Amarillo Biosciences
Amarin
Amicus Therapeutics
Ampio Pharmaceuticals
Amylin Pharmaceuticals
Anesiva
Angiotech Pharmaceuticals
AP Pharma
Apricus Biosciences
Aradigm
Aristos Pharmaceuticals
Arius Pharmaceuticals
Array Biopharma
Astellas
AstraZeneca
Audeo Oncology
Auxilium Pharmaceuticals
AVI Pharma
Azur Pharma
Bausch & Lomb
Baxter International
Bayer
BIND Biosciences
BIND Therapeutics
BioArray Solutions
Biocon
BioCryst Pharmaceuticals
BioDelivery Sciences
Biogen Idec
BiolineRX
Bio-Path
Biopharmex
BioSante Pharmaceuticals
Biovail
BioZone Laboratories
Boehringer Ingelheim
Bristol-Myers Squibb
Calando Pharmaceuticals
Caleco Pharma
Caleco Pharma Europe
Cambridge Laboratories
Cangene
Caraco Pharmaceuticals
Cardinal Health
Cardium Therapeutics
Cary Pharmaceuticals
Catalent Pharma Solutions
Celgene
Celladon
Cerulean Pharma
Clarus Therapeutics
Columbia Laboratories
CombinatoRx
Control Delivery Systems
Corium International
Cornerstone Therapeutics
Cortex Pharmaceuticals
Crawford Healthcare
Critical Therapeutics
CSL
Cubist
Cumberland Pharmaceuticals
Cutanea Life Sciences
Cyclacel Pharmaceuticals
CyDex
Cypress Bioscience
Daiichi Sankyo
Dainippon Sumitomo
Dalian Wande Electronics
Debiopharm
Dechra Pharmaceuticals
Defense Threat Reduction Agency
Dehaier Medical Systems
Dendreon
Department of Defense
Department of Homeland Security
DepoMed
Dey Pharma
Dipexium Pharmaceuticals
DNA Biomedical Solutions
DoctorDirectory
Dov Pharmaceutical
DPT Laboratories
Drugs for Neglected Diseases Initiative
Duoject Medical Systems
Duramed
Durect
Dyax
Echo Therapeutics
ECR Pharmaceuticals
Egalet
Eisai
EKR Therapeutics
Elan
Eli Lilly
Elite Pharmaceuticals
Emergent BioSolutions
Emisphere
Endo Pharmaceuticals
Entera Bio
Epic Pharmaceuticals
Evonik Industries
Facet Biotechnology
FasTrack Pharmaceuticals
Ferndale Pharmaceuticals
Finorga
Fleet Laboratories
Forest Laboratories
Fovea Pharmaceuticals
Fresenius
Galapagos
Galderma
Genentech
Generex Biotechnology
GenVec
Ghent University
Gilead Sciences
GlaxoSmithKline
Global Health Ventures
Globe Laboratories
GlobeImmune
Graceway Pharmaceuticals
Green Vision
Grifols
Hadasit Medical Research Services and Development
Halo Pharmaceutical
Halozyme Therapeutics
Hangzhou Zhencheng Pharmaceuticals
Helix BioMedix
Horizon Pharma AG
Horizon Pharma Inc
Hospira
Hunan Jiuwang Pharmaceuticals
Idenix Pharmaceuticals
Ikaria
ImaRX
Imprimis Pharmaceuticals
Inalco Biochemicals
Inalco Group
Incyte
Inovio Pharmaceuticals
Insmed Inc
Inspire Pharmaceuticals
Intas Biopharmaceuticals
IntelGenx
Intendis
InterMune
Intrexon
Ipsen
Ironwood Pharmaceuticals
Isis Pharmaceuticals
Jagotec
Janssen Pharmaceuticals
Javelin Pharmaceuticals
Jazz Pharmaceuticals
Jiangsu Yabang Pharmaceuticals
Johnson & Johnson
JPI Commercial
King Pharmaceuticals
Krele Pharmaceuticals
Kunwha Pharmaceuticals
KV Pharmaceutical
Kyowa Hakko Kirin
Kythera Biopharmaceuticals
LFB Group
Ligand Pharmaceuticals
Lipocine
Lonza
Los Angeles Biomedical Research Institute
Lundbeck
Lupin Pharmaceuticals
Mallinckrodt Pharmaceuticals
MAP Pharmaceuticals
Marina Biotech
McCoy Enterprises
McKesson
McNeil PPC
MD Anderson Cancer Center
MDRNA
Meda
Medgenics
MediciNova
Medicis Pharma
Medpace
Meiji Seika
Melinta Therapeutics
Memorial Sloan Kettering Cancer Center
Menarini
Merck & Co
Merck KGaA
Merial
Merrimack Pharmaceuticals
Mglas
Microbix Biosystems
MiddleBrook Pharmaceutical
Mikah Pharma
Millennium
Mirna Therapeutics
Mist Acquisition
Monsanto
Morphosys
Mundipharma
Mylan
Mylan Laboratories
Nastech Pharmaceutical
Nektar Therapeutics
NeurogesX
Neuromed
Neuronex
Nitec Pharma
Norgine
NovaDel Pharma
Novartis
Novasep
Novo Nordisk
Novozymes Biopharma
NPS Pharmaceuticals
NuGlow Cosmaceuticals
NuPathe
Nycomed
Oculus Innovative Sciences
Omthera Pharmaceuticals
OncoSec Medical
Onyx Pharmaceuticals
Oradisc
Oramed Pharmaceuticals
Orexigen Therapeutics
Ortho-McNeil-Janssen Pharmaceuticals
Oso Bio Pharmaceuticals
Otsuka
Pacira Pharmaceuticals
Par Pharmaceutical
Patheon
PDL BioPharma
Pfizer
PharmaEngine
Pipex Pharmaceuticals
Planned Systems International (PSI)
Pozen
Prasco Laboratories
Prestige Brands
Procter & Gamble
Professional Compounding Centers of America
ProNAi Therapeutics
PSivida
Purdue
Purdue Pharma
QLT
Questcor Pharmaceuticals
Quintiles
Radius Health
Ranbaxy Laboratories
Receptos
Rechon Life Sciences
RedHill Biopharma
Regeneron Pharmaceuticals
Revance Therapeutics
Rigel Pharmaceuticals
Roche
RRD International
S2 Therapeutics
Sagent Pharmaceuticals
Salix Pharmaceuticals
Sangamo BioSciences
Sankyo Pharmaceutical
Sanofi
Sanofi-Aventis
Santarus
SciClone Pharmaceuticals
Scolr Pharma
Scynexis
Seattle Genetics
Serenity Pharmaceuticals
Servier
Shaanxi Jiali Pharmaceuticals
Shandong Yaoshan Pharmaceuticals
Shionogi
Shire
Sigma-Aldrich
SK Biopharmaceuticals
SkyePharma
SLA Pharma
Smiths Medical
Solvay
Southern Research Institute
Sovereign Pharmaceuticals
Spectrum Pharmaceuticals
Spring Creek Capital
SRI International
Stada
Strakan
Strativa Pharmaceuticals
Sun Pharmaceutical
Supernus Pharmaceuticals
SurModics
Swedish Orphan Biovitrum
Symphony Allegro
Takeda
Tandem Diabetes Care
Tarsa Therapeutics
Teikoku Pharma USA
Teikoku Seiyaku
Teva
The Medical Research, Infrastructure, and Health Services Fund of the Tel Aviv Medical Center
The Medicines Company
The Regents of the University of California
Therabel
Transcept Pharmaceuticals
Transdel Pharmaceuticals
Tranzyme Pharma
TTY Biopharm
UCB
Ultragenyx Pharmaceuticals
Uluru
Unigene Laboratories
United Therapeutics
Valeant
Vanda Pharmaceuticals
Ventrus Biosciences
VeroScience
Vertex Pharmaceuticals
VetCure
Viropharma
WA 32609
Warner Chilcott
Washington Research Foundation
Watson Laboratories
Watson Pharmaceuticals
Xi'an Zaolutang Kushidai Pharmaceuticals
XTL Biopharmaceuticals
Yamasa
Zogenix
ZymoGenetics